Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide After Fontan Operation
NCT00945529Phase 3Completed
- Start
- Feb 2008
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in congenital heart defect (CHD). Started Feb 2008; status: completed.
02
Drugs
nitric oxide
03
Conditions
congenital heart defect (CHD)
Beyond the preview
Go deeper on NCT00945529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945529.